Morgan Stanley Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $61.15 -1.77%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Morgan Stanley upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Equal Weight to Overweight and raised their price target from $28 to $34.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $27.74 yesterday.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $27.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs on Bristol-Myers Squibb Co. (BMY): 'Complicated Setup for Upcoming Admilparant Phase 3 IPF Readout'
- BNP Paribas Exane Upgrades AT&T (T) to Outperform
- Goldman Sachs Upgrades Industrial Bank of Korea (024110:KS) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
